Ameliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemic-reperfusion injury

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 988-994

  Zhang, Yuqin ^a   Zhang, Shengnan ^a   Li, Huang ^a   Huang, Mei ^a   Xu, Wei ^a   Chu, Kedan ^a   Chen, Lidian ^a   Chen, Xianwen ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cytokines; Focal cerebral ischemic reperfusion injury; Gualou Guizhi decoction; Nuclear factor B

Indexed keywords

CHINESE DRUG; GUALOU GUIZHI DECOCTION; INTERLEUKIN 1; INTERLEUKIN 10; NEUROPROTECTIVE AGENT; TRANSCRIPTION FACTOR RELA; TRIPHENYLTETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GUIZHI DECOCTION; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN HISTOLOGY; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROLOGICAL BEHAVIORAL SCORING SYSTEM; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION INJURY; SCORING SYSTEM; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOCHEMISTRY; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GENE EXPRESSION; HISTOCYTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-10; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84926632789     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3515     Document Type: Article

References (36)

1. Donnan GA, Fisher M, Macleod M and Davis SM: Stroke. Lancet 371: 1612-1623, 2008.
2. Huang J, Upadhyay UM and Tamargo RJ: Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66: 232-245, 2006.
3. Klijn CJ and Hankey GJ: Management of acute ischaemic stroke: new guidelines from the American stroke association and European stroke initiative. Lancet Neurol 2: 698-701, 2003.
4. Wu ZS, Yao CH and Zhao D: China's population of stroke morbidity, mortality, epidemiological studies. Chin J Epidemiology 24: 236-239, 2003.
5. Brouns R and De Deyn PP: The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111: 483-495, 2009.
6. Amantea D, Nappi G, Bernardi G, Bagetta G and Corasaniti MT: Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 276: 13-26, 2009.
7. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A and Licata G: Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 14: 3574-3589, 2008.
8. Terao S, Yilmaz G, Stokes KY, Ishikawa M, Kawase T and Granger DN: Inflammatory and injury responses to ischemic stroke in obese mice. Stroke 39: 943-950, 2008.
9. Dirnagl U, Iadecola C and Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397, 1999.
10. Son HY, Han HS, Jung HW and Park YK: Panax notoginseng attenuates the infarct volume in rat ischemic brain and the inflammatory response of microglia. J Pharmacol Sci 109: 368-379, 2009.
11. Han HS and Yenari MA: Cellular targets of brain inflammation in stroke. Curr Opin Investig Drugs 4: 522-529, 2003.
12. Allan SM and Rothwell NJ: Cytokines and acute neurodegeneration. Nat Rev Neurosci 2: 734-744, 2001.
13. Qing Wang, Xian Nan Tang and Midori A Yenari: The inflammatory response in stroke. J Neuroimmuno l184: 53-68, 2007.
14. Yang GY, Gong C, Qin Z, Ye W, Mao Y and Bertz AL: Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuro Report 9: 2131-2134, 1998.
15. Guo RB, Wang GF, Zhao AP, Gu J, Sun XL and Hu G: Paeonifl orin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-κB-mediated infl ammatory responses. PLoS One 7: e49701, 2012.
16. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S and Tarkowski A: Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26: 1393-1398, 1995.
17. Camarata PJ, Heros RC and Latchaw RE: 'Brain attack': the rationale for treating stroke as a medical emergency. Neurosurgery 34: 144-157, 1994.
18. Ringleb PA, Schellinger PD, Schranz C and Hacke W: Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke 33: 1437-1441, 2002.
19. Tao BH, Yang H, Xu ZX and Liu SY: Effect and safety of combined therapy of defibringen, anticoagulation and antiplateletget for progressivity stroke. Chinese General Practice 11: 2134-2136, 2008.
20. Camerlingo M, Salvi P, Belloni G, Cesana BM and Mamoli A: Intravenous heparin started within the fi rst 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke 36: 2415-2420, 2005.
21. Wang W, Ying WB, Bo JL, Wu T and Ding XS: Edaravone clinical safety evaluation. Chinese J Neurology 42: 486-489, 2009.
22. Shuaib A, Lees KR, Lyden P, et al: Emeribe U., SAINT II Trial Investigators: NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357: 1562-1571, 2007.
23. Cho HJ and Kim YJ: Effi cacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases. Methods Find Exp Clin Pharmacol 31: 171-176, 2009.
24. Sun X: Research on formula treating paralysis and spasticity from 'treatise on febrile and miscellaneous diseases'. Chinese Journal of Basic Medicine In Traditional Chinese Medicine 8: 644-645, 2010 (In Chinese).
25. Zhang L and Ai H: Effects of Gua Lou Gui Zhi decoction on c-fos and c-jun in epileptic rats. Journal of Sichuan of Traditional Chinese Medicine 23: 21-22, 2005 (In Chinese).
26. Yang C, Chen L and Tao J: New usage of a classical formula-Gua Lou Gui Zhi decoction. Liaoning Journal of Traditional Chinese Medicine 8: 166-167, 2010 (In Chinese).
27. Hu H, Li Z, Zhu X, et al: Gua Lou Gui Zhi decoction suppresses LPS-induced activation of the TLR4/NF-κB pathway in BV-2 murine microglial cells. Int J Mol Me 31: 1327-1332, 2013.
28. Huang J, Tao J, Xue XH, et al: Gua Lou Gui Zhi decoction exerts neuroprotective effects on post-stroke spasticity via the modulation of glutamate levels and AMPA receptor expression. Inter J Mol Med 31: 841-848, 2013.
29. Muir KW, Tyrrell P, Sattar N and Warburton E: Inflammation and ischaemic stroke. Curr Opin Neurol 20: 334-342, 2007.
30. Han HS and Yenari MA: Cellular targets of brain inflammation in stroke. Curr Opin Investig Drugs 4: 522-529, 2003.
31. Wang ZQ, Wu DC, Huang FP and Yang GY: Inhibition of MEK/ERK 1 and 2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res 996: 55-66, 2004.
32. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC and Feuerstein GZ: Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25: 1481-1488, 1994.
33. Gee JM, Kalil A, Shea C and Becker KJ: Lymphocytes: potential mediators of postischemic injuryand neuroprotection. Stroke 38: 783-788, 2007.
34. Wang XQ, Peng YP, Lu JH, Cao BB and Qiu YH: Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci Lett 450: 122-126, 2009.
35. Baeuerle PA and Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179, 1994.
36. Berti R, Williams AJ, Moffett JR et al: Quantitative real-time RT-PCR analysis of infl ammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab 22: 1068-1079, 2002.